Skip to content

Clinical trials

Phase 2 Adenoma, Islet Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenoma, Islet Cell Phase: Phase 2 Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20051
20061
20082
20102
20111
20121
20132
20141
20152
20161
20171
20181
20191
20201
20212
20223
20232
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated5
Active, not recruiting5
Unknown status3
Recruiting3
Suspended1
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute2
H. Lee Moffitt Cancer Center and Research Institute2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
University of Washington2
Vanderbilt-Ingram Cancer Center2
AC Camargo Cancer Center1
Aadi Bioscience, Inc.1
Alliance for Clinical Trials in Oncology1
Assistance Publique - Hôpitaux de Paris1
Cambridge University Hospitals NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenoma, Islet Cell37
Neuroendocrine Tumors12
Gastrinoma8
Somatostatinoma8
Carcinoid Tumor7
Carcinoma, Islet Cell7
Glucagonoma7
Insulinoma7
Neoplasms7
Neoplasm Metastasis5

Trials

Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.